A Randomized, Open-Label, Crossover Phase 1 Safety and Pharmacokinetic Study of Oral Maraviroc and Maraviroc 1% Gel (the CHARM-03 Study)
一项随机、开放标签、交叉的 1 期口服马拉维罗和 1% 马拉维罗凝胶安全性和药代动力学研究(CHARM-03 研究)
期刊:Aids Research and Human Retroviruses
影响因子:1.1
doi:10.1089/AID.2021.0096
McGowan, Ian M; Chawki, Sylvain; Hendrix, Craig W; Anton, Peter A; Marzinke, Mark A; Brand, Rhonda M; Engstrom, Jarret C; Rohan, Lisa C; Abebe, Kaleab Z; Richardson-Harman, Nicola; Siegel, Aaron; Reinhart, Alex; Steytler, John; Stall, Ronald; Spiegel, Hans; Chen, Beatrice; Achilles, Sharon L; Jacobson, Cindy E; Khanukova, Elena; Cranston, Ross D